Skip to main content

Michelle A. Ghert, MD

Academic Title:

Professor

Primary Appointment:

Orthopaedics

Phone (Primary):

For an appointment call 410-448-6400

Education and Training

  • Stanford University, B.A.S., 1992
  • Vanderbilt University, MD, 1996
  • Duke University, Residency in Orthopaedic Surgery, 2002
  • University of Toronto, Fellowship in Orthopaedic Oncology, 2004

Biosketch

Michelle Ghert, MD, FRCSC, is an orthopaedic surgeon specializing in musculoskeletal oncology. She has extensive experience in the diagnosis and surgical management of benign and malignant tumors of the musculoskeletal system and in complex limb reconstruction. Dr. Ghert is also a national and international leader in sarcoma care and multidisciplinary management. Dr. Ghert leads international randomized controlled trials in orthopaedic oncology, including the Prophylactic Antibiotic Regimens in Tumor Surgery (PARITY) trial (NCT01479283) and the Surveillance after Extremity Tumor Surgery (SAFETY) randomized controlled trial (safetyrct.com, NCT03944798).

Dr. Ghert completed her pre-medical studies at Stanford University in California and received her medical degree from Vanderbilt University in Tennessee. She completed her residency in orthopaedic surgery at Duke University in North Carolina, and her musculoskeletal oncology fellowship at the University of Toronto in Ontario, Canada. She began her independent clinical and academic career as Assistant Professor at McMaster University in Hamilton, Ontario, Canada in 2005, and was promoted to Professor in 2017. Dr. Ghert was recruited to the University of Maryland where she opened her clinical practice in 2024.   

Research/Clinical Keywords

randomized controlled trials,orthopaedic oncology, musculoskeletal tumors, surgery, sarcoma, skeletal metastases

Highlighted Publications

Most Highly Cited Publications

Ghert, Michelle, et al. "Comparison of prophylactic intravenous antibiotic regimens after endoprosthetic reconstruction for lower extremity bone tumors: a randomized clinical trial."JAMA oncology8.3 (2022): 345-353.

Mak, Isabella WY, Nathan Evaniew, and Michelle Ghert. "Lost in translation: animal models and clinical trials in cancer treatment."American journal of translational research  6.2 (2014): 114.

Pervaiz, N., Colterjohn, N., Farrokhyar, F., Tozer, R., Figueredo, A., & Ghert, M. (2008). A systematic meta‐analysis of randomized controlled trials of adjuvant chemotherapy for localized resectable soft‐tissue sarcoma.Cancer: Interdisciplinary International Journal of the American Cancer Society, 113(3), 573-581.

Additional Publication Citations

Awards and Affiliations

Grants and Contracts

×